AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteOxymetazoline is a selective alpha-1 agonist and partial alpha-2 agonist topical decongestant, used in the form of Oxymetazoline hydrochloride.
More Information Supplier PageOxymetazoline is a selective alpha-1 agonist and partial alpha-2 agonist topical decongestant, used in the form of Oxymetazoline hydrochloride.
More Information Supplier PageOxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.
More Information Supplier PageOxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.
More Information Supplier PageOxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.
More Information Supplier PageOxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.
More Information Supplier PageOxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.
More Information Supplier PageOzagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM.
More Information Supplier PageOzagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM.
More Information Supplier PageOzagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM.
More Information Supplier PageOzagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM.
More Information Supplier PageOzagrel is a potent and selective thromboxane A2 synthetase inhibitor with an IC50 of 4 nM.
More Information Supplier PageOzarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageOzarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageOzarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageOzarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageP 22077 is a cell-permeable inhibitor of the ubiquitin-specific protease (IC?? = 8.6 ?M) and the closely related deubiquitinase (DUB) USP47.
More Information Supplier PageP 22077 is a cell-permeable inhibitor of the ubiquitin-specific protease (IC?? = 8.6 ?M) and the closely related deubiquitinase (DUB) USP47.
More Information Supplier PageP 22077 is a cell-permeable inhibitor of the ubiquitin-specific protease (IC?? = 8.6 ?M) and the closely related deubiquitinase (DUB) USP47.
More Information Supplier PageP 22077 is a cell-permeable inhibitor of the ubiquitin-specific protease (IC?? = 8.6 ?M) and the closely related deubiquitinase (DUB) USP47.
More Information Supplier PageP 22077 is a cell-permeable inhibitor of the ubiquitin-specific protease (IC?? = 8.6 ?M) and the closely related deubiquitinase (DUB) USP47.
More Information Supplier PageP-Coumaric acid is an aromatic phytochemical for proteomics research.
More Information Supplier PageP005091 is a selective inhibitor of ubiquitin-specific protease (USP) 7 (IC50 = 4.2 uM).
More Information Supplier PageP005091 is a selective inhibitor of ubiquitin-specific protease (USP) 7 (IC50 = 4.2 uM).
More Information Supplier PageP005091 is a selective inhibitor of ubiquitin-specific protease (USP) 7 (IC50 = 4.2 uM).
More Information Supplier PageP005091 is a selective inhibitor of ubiquitin-specific protease (USP) 7 (IC50 = 4.2 uM).
More Information Supplier PageP005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageP005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageP005672 is a phase II drug for antibacterial/anti-inflammatory acne treatment.
More Information Supplier PageP276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
More Information Supplier PageP276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
More Information Supplier PageP276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
More Information Supplier PageP276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
More Information Supplier PageP505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor chiral is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor chiral is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor chiral is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor racemic is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor racemic is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier Pagep53 and MDM2 proteins-interaction-inhibitor racemic is an inhibitor of the interaction between p53 and MDM2 proteins.
More Information Supplier PageP7C3 is neurogenic and protects new neurons against apoptosis. It protects newborn neurons in the dentate gyrus and stimulates the growth of new neurons.
More Information Supplier PageP7C3 is neurogenic and protects new neurons against apoptosis. It protects newborn neurons in the dentate gyrus and stimulates the growth of new neurons.
More Information Supplier PageP7C3 is neurogenic and protects new neurons against apoptosis. It protects newborn neurons in the dentate gyrus and stimulates the growth of new neurons.
More Information Supplier Page
